BWXT to supply Ac-225 generation to Fusion Pharmaceuticals
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
Ageing nuclear assets don't have to mean higher maintenance costs. Discover how HVTS® cladding helps extend the life of PWR secondary system components, reduce outage duration, support ALARA principles, and protect against FAC, erosion-corrosion and other degradation mechanisms. Learn more.
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
Bruce Power’s hot cell approved for medical isotope production
The Canadian Nuclear Safety Commission has given Bruce Power approval to operate the company’s hot cell facility in Tiverton, Ontario, for medical radioisotope processing. This approval...

New lab at ORNL speeds up U-233 cleanup, Ac-225 delivery
A new analytical laboratory at Oak Ridge National Laboratory has been officially opened by the Department of Energy’s Oak Ridge Office of Environmental Management and its contractor Isotek...
Ontario invests in medical radioisotope production at McMaster
With a new investment of C$4.6 million (approximately $3.3 million) from the government of Ontario, Canada, operations of the McMaster Nuclear Reactor (MNR) at McMaster University are being...

DOE issues RFI for reuse of SRS heavy water
The Department of Energy’s Office of Environmental Management has issued a request for information for industry input about the best ways to reuse and repurpose as much as 530,000 gallons of...
DOE, PNNL, and Commerce Dept. collaborate on Ra-226 recovery
A collaboration between the Department of Energy’s Office of Isotope R&D and Production and the Department of Commerce’s National Institute of Standards and Technology has recovered...
Reimagining nuclear materials for the future of medicine
Nuclear medicine has come a long way since Henri Becquerel first observed the penetrating energy of radioactive materials in 1896. Today, technetium-99m alone is used in more than 40 million...
Canada funds fusion-based copper-67 production project
The Canadian Medical Isotope Ecosystem, which is backed by the Canadian federal government’s Strategic Innovation Fund, has announced funding for a collaboration between Promation, Astral...

TerraPower announces second Ac-225 production facility
TerraPower Isotopes, a TerraPower subsidiary, plans to increase its actinium-225 production 20-fold by opening a new manufacturing facility in Philadelphia, Pa., and by expanding the capacity...

ANSTO-designed target increases Mo-99 yield
The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...
Westinghouse teams with Nordion and PSEG to produce Co-60 at Salem
Westinghouse Electric Company, Nordion, and PSEG Nuclear announced on Tuesday the signing of long-term agreements to establish the first commercial-scale production of cobalt-60 in a U.S....
